A detailed history of Core Alternative Capital transactions in Perkinelmer Inc stock. As of the latest transaction made, Core Alternative Capital holds 4 shares of PKI stock, worth $484. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$484
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
N/A
-69 Reduced 94.52%
4 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-3 Reduced 3.95%
73 $8,000
Q2 2023

Jul 27, 2023

BUY
$0.0 - $137.11 $0 - $959
7 Added 10.14%
76 $0
Q1 2023

Apr 18, 2023

BUY
$120.16 - $144.38 $841 - $1,010
7 Added 11.29%
69 $9,000
Q2 2022

Aug 01, 2022

BUY
$134.91 - $172.49 $2,833 - $3,622
21 Added 51.22%
62 $9,000
Q1 2022

May 10, 2022

BUY
$162.31 - $192.2 $4,544 - $5,381
28 Added 215.38%
41 $7,000
Q4 2021

Feb 11, 2022

BUY
$166.66 - $201.06 $2,166 - $2,613
13 New
13 $3,000

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.